img

Global Aminoglycoside Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Aminoglycoside Drug Market Insights, Forecast to 2034

Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.
Global Aminoglycoside Drug market is expected to reach to US$ 1070 million in 2024, with a positive growth of %, compared with US$ 1056 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Aminoglycoside Drug industry is evaluated to reach US$ 1102.5 million in 2029. The CAGR will be 0.5% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Aminoglycoside Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Aminoglycoside Drug market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Jemicare
Teva
Novartis Pharmaceuticals
Fangyuan-pharma
Aike Pharmaceutical
Cipla
Pfizer
FRESENIUS KABI
Sun Pharma
Hikma
Lannett Company
Segment by Type
Neomycin
Tobramycin
Gentamicin
Amikacin
Etimicin
Others

Segment by Application


Hospital
Retail Pharmacy
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Aminoglycoside Drug plant distribution, commercial date of Aminoglycoside Drug, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Aminoglycoside Drug introduction, etc. Aminoglycoside Drug Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Aminoglycoside Drug
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Aminoglycoside Drug Product Introduction
1.2 Market by Type
1.2.1 Global Aminoglycoside Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Neomycin
1.2.3 Tobramycin
1.2.4 Gentamicin
1.2.5 Amikacin
1.2.6 Etimicin
1.2.7 Others
1.3 Market by Application
1.3.1 Global Aminoglycoside Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Aminoglycoside Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Aminoglycoside Drug Revenue by Region
2.2.1 Global Aminoglycoside Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Aminoglycoside Drug Revenue by Region (2018-2024)
2.2.3 Global Aminoglycoside Drug Revenue by Region (2024-2029)
2.2.4 Global Aminoglycoside Drug Revenue Market Share by Region (2018-2029)
2.3 Global Aminoglycoside Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Aminoglycoside Drug Sales by Region
2.4.1 Global Aminoglycoside Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Aminoglycoside Drug Sales by Region (2018-2024)
2.4.3 Global Aminoglycoside Drug Sales by Region (2024-2029)
2.4.4 Global Aminoglycoside Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Aminoglycoside Drug Sales by Manufacturers
3.1.1 Global Aminoglycoside Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Aminoglycoside Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Aminoglycoside Drug in 2022
3.2 Global Aminoglycoside Drug Revenue by Manufacturers
3.2.1 Global Aminoglycoside Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Aminoglycoside Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Aminoglycoside Drug Revenue in 2022
3.3 Global Key Players of Aminoglycoside Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Aminoglycoside Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Aminoglycoside Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Aminoglycoside Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Aminoglycoside Drug, Product Offered and Application
3.8 Global Key Manufacturers of Aminoglycoside Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Aminoglycoside Drug Sales by Type
4.1.1 Global Aminoglycoside Drug Historical Sales by Type (2018-2024)
4.1.2 Global Aminoglycoside Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Aminoglycoside Drug Sales Market Share by Type (2018-2029)
4.2 Global Aminoglycoside Drug Revenue by Type
4.2.1 Global Aminoglycoside Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Aminoglycoside Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Aminoglycoside Drug Revenue Market Share by Type (2018-2029)
4.3 Global Aminoglycoside Drug Price by Type
4.3.1 Global Aminoglycoside Drug Price by Type (2018-2024)
4.3.2 Global Aminoglycoside Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Aminoglycoside Drug Sales by Application
5.1.1 Global Aminoglycoside Drug Historical Sales by Application (2018-2024)
5.1.2 Global Aminoglycoside Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Aminoglycoside Drug Sales Market Share by Application (2018-2029)
5.2 Global Aminoglycoside Drug Revenue by Application
5.2.1 Global Aminoglycoside Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Aminoglycoside Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Aminoglycoside Drug Revenue Market Share by Application (2018-2029)
5.3 Global Aminoglycoside Drug Price by Application
5.3.1 Global Aminoglycoside Drug Price by Application (2018-2024)
5.3.2 Global Aminoglycoside Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Aminoglycoside Drug Market Size by Type
6.1.1 US & Canada Aminoglycoside Drug Sales by Type (2018-2029)
6.1.2 US & Canada Aminoglycoside Drug Revenue by Type (2018-2029)
6.2 US & Canada Aminoglycoside Drug Market Size by Application
6.2.1 US & Canada Aminoglycoside Drug Sales by Application (2018-2029)
6.2.2 US & Canada Aminoglycoside Drug Revenue by Application (2018-2029)
6.3 US & Canada Aminoglycoside Drug Market Size by Country
6.3.1 US & Canada Aminoglycoside Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Aminoglycoside Drug Sales by Country (2018-2029)
6.3.3 US & Canada Aminoglycoside Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Aminoglycoside Drug Market Size by Type
7.1.1 Europe Aminoglycoside Drug Sales by Type (2018-2029)
7.1.2 Europe Aminoglycoside Drug Revenue by Type (2018-2029)
7.2 Europe Aminoglycoside Drug Market Size by Application
7.2.1 Europe Aminoglycoside Drug Sales by Application (2018-2029)
7.2.2 Europe Aminoglycoside Drug Revenue by Application (2018-2029)
7.3 Europe Aminoglycoside Drug Market Size by Country
7.3.1 Europe Aminoglycoside Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Aminoglycoside Drug Sales by Country (2018-2029)
7.3.3 Europe Aminoglycoside Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Aminoglycoside Drug Market Size
8.1.1 China Aminoglycoside Drug Sales (2018-2029)
8.1.2 China Aminoglycoside Drug Revenue (2018-2029)
8.2 China Aminoglycoside Drug Market Size by Application
8.2.1 China Aminoglycoside Drug Sales by Application (2018-2029)
8.2.2 China Aminoglycoside Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Aminoglycoside Drug Market Size by Type
9.1.1 Asia Aminoglycoside Drug Sales by Type (2018-2029)
9.1.2 Asia Aminoglycoside Drug Revenue by Type (2018-2029)
9.2 Asia Aminoglycoside Drug Market Size by Application
9.2.1 Asia Aminoglycoside Drug Sales by Application (2018-2029)
9.2.2 Asia Aminoglycoside Drug Revenue by Application (2018-2029)
9.3 Asia Aminoglycoside Drug Sales by Region
9.3.1 Asia Aminoglycoside Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Aminoglycoside Drug Revenue by Region (2018-2029)
9.3.3 Asia Aminoglycoside Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Aminoglycoside Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Aminoglycoside Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Aminoglycoside Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Aminoglycoside Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Aminoglycoside Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Aminoglycoside Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Aminoglycoside Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Aminoglycoside Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Aminoglycoside Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Aminoglycoside Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Jemicare
11.1.1 Jemicare Company Information
11.1.2 Jemicare Overview
11.1.3 Jemicare Aminoglycoside Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Jemicare Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Jemicare Recent Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Overview
11.2.3 Teva Aminoglycoside Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Teva Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Recent Developments
11.3 Novartis Pharmaceuticals
11.3.1 Novartis Pharmaceuticals Company Information
11.3.2 Novartis Pharmaceuticals Overview
11.3.3 Novartis Pharmaceuticals Aminoglycoside Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Novartis Pharmaceuticals Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Pharmaceuticals Recent Developments
11.4 Fangyuan-pharma
11.4.1 Fangyuan-pharma Company Information
11.4.2 Fangyuan-pharma Overview
11.4.3 Fangyuan-pharma Aminoglycoside Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Fangyuan-pharma Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Fangyuan-pharma Recent Developments
11.5 Aike Pharmaceutical
11.5.1 Aike Pharmaceutical Company Information
11.5.2 Aike Pharmaceutical Overview
11.5.3 Aike Pharmaceutical Aminoglycoside Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Aike Pharmaceutical Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Aike Pharmaceutical Recent Developments
11.6 Cipla
11.6.1 Cipla Company Information
11.6.2 Cipla Overview
11.6.3 Cipla Aminoglycoside Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Cipla Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Cipla Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Information
11.7.2 Pfizer Overview
11.7.3 Pfizer Aminoglycoside Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Pfizer Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Pfizer Recent Developments
11.8 FRESENIUS KABI
11.8.1 FRESENIUS KABI Company Information
11.8.2 FRESENIUS KABI Overview
11.8.3 FRESENIUS KABI Aminoglycoside Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 FRESENIUS KABI Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 FRESENIUS KABI Recent Developments
11.9 Sun Pharma
11.9.1 Sun Pharma Company Information
11.9.2 Sun Pharma Overview
11.9.3 Sun Pharma Aminoglycoside Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Sun Pharma Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sun Pharma Recent Developments
11.10 Hikma
11.10.1 Hikma Company Information
11.10.2 Hikma Overview
11.10.3 Hikma Aminoglycoside Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Hikma Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Hikma Recent Developments
11.11 Lannett Company
11.11.1 Lannett Company Company Information
11.11.2 Lannett Company Overview
11.11.3 Lannett Company Aminoglycoside Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Lannett Company Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Lannett Company Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Aminoglycoside Drug Industry Chain Analysis
12.2 Aminoglycoside Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Aminoglycoside Drug Production Mode & Process
12.4 Aminoglycoside Drug Sales and Marketing
12.4.1 Aminoglycoside Drug Sales Channels
12.4.2 Aminoglycoside Drug Distributors
12.5 Aminoglycoside Drug Customers
13 Market Dynamics
13.1 Aminoglycoside Drug Industry Trends
13.2 Aminoglycoside Drug Market Drivers
13.3 Aminoglycoside Drug Market Challenges
13.4 Aminoglycoside Drug Market Restraints
14 Key Findings in The Global Aminoglycoside Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Aminoglycoside Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Neomycin
Table 3. Major Manufacturers of Tobramycin
Table 4. Major Manufacturers of Gentamicin
Table 5. Major Manufacturers of Amikacin
Table 6. Major Manufacturers of Etimicin
Table 7. Major Manufacturers of Others
Table 8. Global Aminoglycoside Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Aminoglycoside Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Aminoglycoside Drug Revenue by Region (2018-2024) & (US$ Million)
Table 11. Global Aminoglycoside Drug Revenue by Region (2024-2029) & (US$ Million)
Table 12. Global Aminoglycoside Drug Revenue Market Share by Region (2018-2024)
Table 13. Global Aminoglycoside Drug Revenue Market Share by Region (2024-2029)
Table 14. Global Aminoglycoside Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 15. Global Aminoglycoside Drug Sales by Region (2018-2024) & (K Units)
Table 16. Global Aminoglycoside Drug Sales by Region (2024-2029) & (K Units)
Table 17. Global Aminoglycoside Drug Sales Market Share by Region (2018-2024)
Table 18. Global Aminoglycoside Drug Sales Market Share by Region (2024-2029)
Table 19. Global Aminoglycoside Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 20. Global Aminoglycoside Drug Sales Share by Manufacturers (2018-2024)
Table 21. Global Aminoglycoside Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 22. Global Aminoglycoside Drug Revenue Share by Manufacturers (2018-2024)
Table 23. Global Key Players of Aminoglycoside Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 24. Aminoglycoside Drug Price by Manufacturers 2018-2024 (US$/Unit)
Table 25. Global Aminoglycoside Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Aminoglycoside Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aminoglycoside Drug as of 2022)
Table 27. Global Key Manufacturers of Aminoglycoside Drug, Manufacturing Base Distribution and Headquarters
Table 28. Global Key Manufacturers of Aminoglycoside Drug, Product Offered and Application
Table 29. Global Key Manufacturers of Aminoglycoside Drug, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Aminoglycoside Drug Sales by Type (2018-2024) & (K Units)
Table 32. Global Aminoglycoside Drug Sales by Type (2024-2029) & (K Units)
Table 33. Global Aminoglycoside Drug Sales Share by Type (2018-2024)
Table 34. Global Aminoglycoside Drug Sales Share by Type (2024-2029)
Table 35. Global Aminoglycoside Drug Revenue by Type (2018-2024) & (US$ Million)
Table 36. Global Aminoglycoside Drug Revenue by Type (2024-2029) & (US$ Million)
Table 37. Global Aminoglycoside Drug Revenue Share by Type (2018-2024)
Table 38. Global Aminoglycoside Drug Revenue Share by Type (2024-2029)
Table 39. Aminoglycoside Drug Price by Type (2018-2024) & (US$/Unit)
Table 40. Global Aminoglycoside Drug Price Forecast by Type (2024-2029) & (US$/Unit)
Table 41. Global Aminoglycoside Drug Sales by Application (2018-2024) & (K Units)
Table 42. Global Aminoglycoside Drug Sales by Application (2024-2029) & (K Units)
Table 43. Global Aminoglycoside Drug Sales Share by Application (2018-2024)
Table 44. Global Aminoglycoside Drug Sales Share by Application (2024-2029)
Table 45. Global Aminoglycoside Drug Revenue by Application (2018-2024) & (US$ Million)
Table 46. Global Aminoglycoside Drug Revenue by Application (2024-2029) & (US$ Million)
Table 47. Global Aminoglycoside Drug Revenue Share by Application (2018-2024)
Table 48. Global Aminoglycoside Drug Revenue Share by Application (2024-2029)
Table 49. Aminoglycoside Drug Price by Application (2018-2024) & (US$/Unit)
Table 50. Global Aminoglycoside Drug Price Forecast by Application (2024-2029) & (US$/Unit)
Table 51. US & Canada Aminoglycoside Drug Sales by Type (2018-2024) & (K Units)
Table 52. US & Canada Aminoglycoside Drug Sales by Type (2024-2029) & (K Units)
Table 53. US & Canada Aminoglycoside Drug Revenue by Type (2018-2024) & (US$ Million)
Table 54. US & Canada Aminoglycoside Drug Revenue by Type (2024-2029) & (US$ Million)
Table 55. US & Canada Aminoglycoside Drug Sales by Application (2018-2024) & (K Units)
Table 56. US & Canada Aminoglycoside Drug Sales by Application (2024-2029) & (K Units)
Table 57. US & Canada Aminoglycoside Drug Revenue by Application (2018-2024) & (US$ Million)
Table 58. US & Canada Aminoglycoside Drug Revenue by Application (2024-2029) & (US$ Million)
Table 59. US & Canada Aminoglycoside Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 60. US & Canada Aminoglycoside Drug Revenue by Country (2018-2024) & (US$ Million)
Table 61. US & Canada Aminoglycoside Drug Revenue by Country (2024-2029) & (US$ Million)
Table 62. US & Canada Aminoglycoside Drug Sales by Country (2018-2024) & (K Units)
Table 63. US & Canada Aminoglycoside Drug Sales by Country (2024-2029) & (K Units)
Table 64. Europe Aminoglycoside Drug Sales by Type (2018-2024) & (K Units)
Table 65. Europe Aminoglycoside Drug Sales by Type (2024-2029) & (K Units)
Table 66. Europe Aminoglycoside Drug Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Aminoglycoside Drug Revenue by Type (2024-2029) & (US$ Million)
Table 68. Europe Aminoglycoside Drug Sales by Application (2018-2024) & (K Units)
Table 69. Europe Aminoglycoside Drug Sales by Application (2024-2029) & (K Units)
Table 70. Europe Aminoglycoside Drug Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Aminoglycoside Drug Revenue by Application (2024-2029) & (US$ Million)
Table 72. Europe Aminoglycoside Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 73. Europe Aminoglycoside Drug Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Aminoglycoside Drug Revenue by Country (2024-2029) & (US$ Million)
Table 75. Europe Aminoglycoside Drug Sales by Country (2018-2024) & (K Units)
Table 76. Europe Aminoglycoside Drug Sales by Country (2024-2029) & (K Units)
Table 77. China Aminoglycoside Drug Sales by Type (2018-2024) & (K Units)
Table 78. China Aminoglycoside Drug Sales by Type (2024-2029) & (K Units)
Table 79. China Aminoglycoside Drug Revenue by Type (2018-2024) & (US$ Million)
Table 80. China Aminoglycoside Drug Revenue by Type (2024-2029) & (US$ Million)
Table 81. China Aminoglycoside Drug Sales by Application (2018-2024) & (K Units)
Table 82. China Aminoglycoside Drug Sales by Application (2024-2029) & (K Units)
Table 83. China Aminoglycoside Drug Revenue by Application (2018-2024) & (US$ Million)
Table 84. China Aminoglycoside Drug Revenue by Application (2024-2029) & (US$ Million)
Table 85. Asia Aminoglycoside Drug Sales by Type (2018-2024) & (K Units)
Table 86. Asia Aminoglycoside Drug Sales by Type (2024-2029) & (K Units)
Table 87. Asia Aminoglycoside Drug Revenue by Type (2018-2024) & (US$ Million)
Table 88. Asia Aminoglycoside Drug Revenue by Type (2024-2029) & (US$ Million)
Table 89. Asia Aminoglycoside Drug Sales by Application (2018-2024) & (K Units)
Table 90. Asia Aminoglycoside Drug Sales by Application (2024-2029) & (K Units)
Table 91. Asia Aminoglycoside Drug Revenue by Application (2018-2024) & (US$ Million)
Table 92. Asia Aminoglycoside Drug Revenue by Application (2024-2029) & (US$ Million)
Table 93. Asia Aminoglycoside Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 94. Asia Aminoglycoside Drug Revenue by Region (2018-2024) & (US$ Million)
Table 95. Asia Aminoglycoside Drug Revenue by Region (2024-2029) & (US$ Million)
Table 96. Asia Aminoglycoside Drug Sales by Region (2018-2024) & (K Units)
Table 97. Asia Aminoglycoside Drug Sales by Region (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Aminoglycoside Drug Sales by Type (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Aminoglycoside Drug Sales by Type (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Aminoglycoside Drug Revenue by Type (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Aminoglycoside Drug Revenue by Type (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Aminoglycoside Drug Sales by Application (2018-2024) & (K Units)
Table 103. Middle East, Africa and Latin America Aminoglycoside Drug Sales by Application (2024-2029) & (K Units)
Table 104. Middle East, Africa and Latin America Aminoglycoside Drug Revenue by Application (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Aminoglycoside Drug Revenue by Application (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Aminoglycoside Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 107. Middle East, Africa and Latin America Aminoglycoside Drug Revenue by Country (2018-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America Aminoglycoside Drug Revenue by Country (2024-2029) & (US$ Million)
Table 109. Middle East, Africa and Latin America Aminoglycoside Drug Sales by Country (2018-2024) & (K Units)
Table 110. Middle East, Africa and Latin America Aminoglycoside Drug Sales by Country (2024-2029) & (K Units)
Table 111. Jemicare Company Information
Table 112. Jemicare Description and Major Businesses
Table 113. Jemicare Aminoglycoside Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 114. Jemicare Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Jemicare Recent Developments
Table 116. Teva Company Information
Table 117. Teva Description and Major Businesses
Table 118. Teva Aminoglycoside Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 119. Teva Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Teva Recent Developments
Table 121. Novartis Pharmaceuticals Company Information
Table 122. Novartis Pharmaceuticals Description and Major Businesses
Table 123. Novartis Pharmaceuticals Aminoglycoside Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 124. Novartis Pharmaceuticals Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Novartis Pharmaceuticals Recent Developments
Table 126. Fangyuan-pharma Company Information
Table 127. Fangyuan-pharma Description and Major Businesses
Table 128. Fangyuan-pharma Aminoglycoside Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 129. Fangyuan-pharma Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Fangyuan-pharma Recent Developments
Table 131. Aike Pharmaceutical Company Information
Table 132. Aike Pharmaceutical Description and Major Businesses
Table 133. Aike Pharmaceutical Aminoglycoside Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 134. Aike Pharmaceutical Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Aike Pharmaceutical Recent Developments
Table 136. Cipla Company Information
Table 137. Cipla Description and Major Businesses
Table 138. Cipla Aminoglycoside Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 139. Cipla Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Cipla Recent Developments
Table 141. Pfizer Company Information
Table 142. Pfizer Description and Major Businesses
Table 143. Pfizer Aminoglycoside Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 144. Pfizer Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Pfizer Recent Developments
Table 146. FRESENIUS KABI Company Information
Table 147. FRESENIUS KABI Description and Major Businesses
Table 148. FRESENIUS KABI Aminoglycoside Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 149. FRESENIUS KABI Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. FRESENIUS KABI Recent Developments
Table 151. Sun Pharma Company Information
Table 152. Sun Pharma Description and Major Businesses
Table 153. Sun Pharma Aminoglycoside Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 154. Sun Pharma Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Sun Pharma Recent Developments
Table 156. Hikma Company Information
Table 157. Hikma Description and Major Businesses
Table 158. Hikma Aminoglycoside Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 159. Hikma Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Hikma Recent Developments
Table 161. Lannett Company Company Information
Table 162. Lannett Company Description and Major Businesses
Table 163. Lannett Company Aminoglycoside Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 164. Lannett Company Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Lannett Company Recent Developments
Table 166. Key Raw Materials Lists
Table 167. Raw Materials Key Suppliers Lists
Table 168. Aminoglycoside Drug Distributors List
Table 169. Aminoglycoside Drug Customers List
Table 170. Aminoglycoside Drug Market Trends
Table 171. Aminoglycoside Drug Market Drivers
Table 172. Aminoglycoside Drug Market Challenges
Table 173. Aminoglycoside Drug Market Restraints
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Aminoglycoside Drug Product Picture
Figure 2. Global Aminoglycoside Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Aminoglycoside Drug Market Share by Type in 2022 & 2029
Figure 4. Neomycin Product Picture
Figure 5. Tobramycin Product Picture
Figure 6. Gentamicin Product Picture
Figure 7. Amikacin Product Picture
Figure 8. Etimicin Product Picture
Figure 9. Others Product Picture
Figure 10. Global Aminoglycoside Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 11. Global Aminoglycoside Drug Market Share by Application in 2022 & 2029
Figure 12. Hospital
Figure 13. Retail Pharmacy
Figure 14. Others
Figure 15. Aminoglycoside Drug Report Years Considered
Figure 16. Global Aminoglycoside Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Aminoglycoside Drug Revenue 2018-2029 (US$ Million)
Figure 18. Global Aminoglycoside Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 19. Global Aminoglycoside Drug Revenue Market Share by Region (2018-2029)
Figure 20. Global Aminoglycoside Drug Sales 2018-2029 ((K Units)
Figure 21. Global Aminoglycoside Drug Sales Market Share by Region (2018-2029)
Figure 22. US & Canada Aminoglycoside Drug Sales YoY (2018-2029) & (K Units)
Figure 23. US & Canada Aminoglycoside Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Europe Aminoglycoside Drug Sales YoY (2018-2029) & (K Units)
Figure 25. Europe Aminoglycoside Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 26. China Aminoglycoside Drug Sales YoY (2018-2029) & (K Units)
Figure 27. China Aminoglycoside Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Asia (excluding China) Aminoglycoside Drug Sales YoY (2018-2029) & (K Units)
Figure 29. Asia (excluding China) Aminoglycoside Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Aminoglycoside Drug Sales YoY (2018-2029) & (K Units)
Figure 31. Middle East, Africa and Latin America Aminoglycoside Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 32. The Aminoglycoside Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 33. The Top 5 and 10 Largest Manufacturers of Aminoglycoside Drug in the World: Market Share by Aminoglycoside Drug Revenue in 2022
Figure 34. Global Aminoglycoside Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 35. Global Aminoglycoside Drug Sales Market Share by Type (2018-2029)
Figure 36. Global Aminoglycoside Drug Revenue Market Share by Type (2018-2029)
Figure 37. Global Aminoglycoside Drug Sales Market Share by Application (2018-2029)
Figure 38. Global Aminoglycoside Drug Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Aminoglycoside Drug Sales Market Share by Type (2018-2029)
Figure 40. US & Canada Aminoglycoside Drug Revenue Market Share by Type (2018-2029)
Figure 41. US & Canada Aminoglycoside Drug Sales Market Share by Application (2018-2029)
Figure 42. US & Canada Aminoglycoside Drug Revenue Market Share by Application (2018-2029)
Figure 43. US & Canada Aminoglycoside Drug Revenue Share by Country (2018-2029)
Figure 44. US & Canada Aminoglycoside Drug Sales Share by Country (2018-2029)
Figure 45. U.S. Aminoglycoside Drug Revenue (2018-2029) & (US$ Million)
Figure 46. Canada Aminoglycoside Drug Revenue (2018-2029) & (US$ Million)
Figure 47. Europe Aminoglycoside Drug Sales Market Share by Type (2018-2029)
Figure 48. Europe Aminoglycoside Drug Revenue Market Share by Type (2018-2029)
Figure 49. Europe Aminoglycoside Drug Sales Market Share by Application (2018-2029)
Figure 50. Europe Aminoglycoside Drug Revenue Market Share by Application (2018-2029)
Figure 51. Europe Aminoglycoside Drug Revenue Share by Country (2018-2029)
Figure 52. Europe Aminoglycoside Drug Sales Share by Country (2018-2029)
Figure 53. Germany Aminoglycoside Drug Revenue (2018-2029) & (US$ Million)
Figure 54. France Aminoglycoside Drug Revenue (2018-2029) & (US$ Million)
Figure 55. U.K. Aminoglycoside Drug Revenue (2018-2029) & (US$ Million)
Figure 56. Italy Aminoglycoside Drug Revenue (2018-2029) & (US$ Million)
Figure 57. Russia Aminoglycoside Drug Revenue (2018-2029) & (US$ Million)
Figure 58. China Aminoglycoside Drug Sales Market Share by Type (2018-2029)
Figure 59. China Aminoglycoside Drug Revenue Market Share by Type (2018-2029)
Figure 60. China Aminoglycoside Drug Sales Market Share by Application (2018-2029)
Figure 61. China Aminoglycoside Drug Revenue Market Share by Application (2018-2029)
Figure 62. Asia Aminoglycoside Drug Sales Market Share by Type (2018-2029)
Figure 63. Asia Aminoglycoside Drug Revenue Market Share by Type (2018-2029)
Figure 64. Asia Aminoglycoside Drug Sales Market Share by Application (2018-2029)
Figure 65. Asia Aminoglycoside Drug Revenue Market Share by Application (2018-2029)
Figure 66. Asia Aminoglycoside Drug Revenue Share by Region (2018-2029)
Figure 67. Asia Aminoglycoside Drug Sales Share by Region (2018-2029)
Figure 68. Japan Aminoglycoside Drug Revenue (2018-2029) & (US$ Million)
Figure 69. South Korea Aminoglycoside Drug Revenue (2018-2029) & (US$ Million)
Figure 70. China Taiwan Aminoglycoside Drug Revenue (2018-2029) & (US$ Million)
Figure 71. Southeast Asia Aminoglycoside Drug Revenue (2018-2029) & (US$ Million)
Figure 72. India Aminoglycoside Drug Revenue (2018-2029) & (US$ Million)
Figure 73. Middle East, Africa and Latin America Aminoglycoside Drug Sales Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Aminoglycoside Drug Revenue Market Share by Type (2018-2029)
Figure 75. Middle East, Africa and Latin America Aminoglycoside Drug Sales Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Aminoglycoside Drug Revenue Market Share by Application (2018-2029)
Figure 77. Middle East, Africa and Latin America Aminoglycoside Drug Revenue Share by Country (2018-2029)
Figure 78. Middle East, Africa and Latin America Aminoglycoside Drug Sales Share by Country (2018-2029)
Figure 79. Brazil Aminoglycoside Drug Revenue (2018-2029) & (US$ Million)
Figure 80. Mexico Aminoglycoside Drug Revenue (2018-2029) & (US$ Million)
Figure 81. Turkey Aminoglycoside Drug Revenue (2018-2029) & (US$ Million)
Figure 82. Israel Aminoglycoside Drug Revenue (2018-2029) & (US$ Million)
Figure 83. GCC Countries Aminoglycoside Drug Revenue (2018-2029) & (US$ Million)
Figure 84. Aminoglycoside Drug Value Chain
Figure 85. Aminoglycoside Drug Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries